Literature DB >> 24695400

Hydrogel-fibre composites with independent control over cell adhesion to gel and fibres as an integral approach towards a biomimetic artificial ECM.

Vera A Schulte1, Kathrin Hahn, Anandhan Dhanasingh, Karl-Heinz Heffels, Jürgen Groll.   

Abstract

In the body, cells are surrounded by an interconnected mesh of insoluble, bioactive protein fibres to which they adhere in a well-controlled manner, embedded in a hydrogel-like highly hydrated matrix. True morphological and biochemical mimicry of this so-called extracellular matrix (ECM) remains a challenge but appears decisive for a successful design of biomimetic three-dimensional in vitro cell culture systems. Herein, an approach is presented which describes the fabrication and in vitro assessment of an artificial ECM which contains two major components, i.e. specifically biofunctionalized fibres and a semi-synthetic hyaluronic acid-based hydrogel, which allows control over cell adhesion towards both components. As proof of principle for the control of cell adhesion, RGD as well-known cell adhesive cue and the control sequence RGE are immobilized in the system. In vitro studies with primary human dermal fibroblasts were conducted to evaluate the specificity of cell adhesion and the potential of the composite system to support cell growth. Finally, one possible application example for guided cell growth is shown by the use of oriented fibres in a hydrogel matrix.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24695400     DOI: 10.1088/1758-5082/6/2/024106

Source DB:  PubMed          Journal:  Biofabrication        ISSN: 1758-5082            Impact factor:   9.954


  2 in total

1.  Advanced micro- and nanofabrication technologies for tissue engineering.

Authors:  Assaf Shapira; Deok-Ho Kim; Tal Dvir
Journal:  Biofabrication       Date:  2014-05-30       Impact factor: 9.954

Review 2.  Recent Advances in Fiber-Hydrogel Composites for Wound Healing and Drug Delivery Systems.

Authors:  Marta O Teixeira; Joana C Antunes; Helena P Felgueiras
Journal:  Antibiotics (Basel)       Date:  2021-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.